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Several 2-alkylquinolizinium-1-olates 9, i.e. heterobetaines, were prepared from 
ketone 11, the latter being readily available either from 2-pyridine carbaldehyde via a 
Grignard reaction followed by oxidation with MnO2 or from 2-picolinic acid via the 
corresponding Weinreb amide and subsequent Grignard reaction. Mesoionic heterobetaines 
such as quinolizinium derivatives have the potential to undergo cycloaddition reactions with 
double and triple bonds, e.g. 1,3-dipolar cycloadditions or Diels-Alder reactions. We here 
report on the scope and limitations of cycloadditions of 2-alkylquinolizinium-1-olates 9 with 
electron-poor acetylene derivatives. As main products of the reaction, [2.3.3]cyclazin-5-ones 
19 were formed via a regioselective [2+3]-cycloaddition, and cyclohexadienone derivatives, 
formed via a Diels-Alder reaction, were obtained as side products. The structures of 2-
benzylquinolizinium-1-olate (9a) and two [2.3.3]cyclazin-5-ones 19i and 19l were established 
by X-ray crystallography. 
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1. Introduction. – Since the formulation of the concept of 1,3-dipolar cycloadditions  
([2+3] cycloadditions) by Huisgen [1], this reaction type proved to be an indispensable tool 
for the synthesis of five-membered heterocycles [2].  Belonging to the pericyclic reactions, 
the special features of [2+3] cycloadditions such as chemo-, regio-, and stereoselectivity are 
nowadays well understood on the basis of the Frontier Molecular Orbital (FMO) theory [3], 
and the Woodward-Hoffmann [4] and Dewar-Zimmerman rules [5] allow reliable predictions 
of the reaction course and the structure of the products. But an increasing number of formal 
1,3-dipolar cycloadditions is known, in which a non-concerted, two-step mechanism [6] via 
either a biradical [7] or a zwitterion [8] as the crucial intermediate leads to the five-membered 
products. 
 An important and often used group of 1,3-dipoles used in [2+3] cycloadditions 
consists of azomethine ylides, which can be generated as reactive intermediates by various 
methods such as thermal and photochemical ring-opening of aziridines, deprotonation of 
iminium salts, desilylation of silylated amines and imines, base-catalyzed elimination of 
thiophenol from 2-(phenylsulfanyl)amines, thermal decarboxylation of 1,3-oxazolidin-5-ones, 
and dehydration of  N-oxides of tertiary amines [9]. In addition, a series of relatively stable 
azomethine ylides has been described, in which the formal charges are stabilized by extended 
delocalization or electron-withdrawing substituents. Well-known examples are pyridinium, 
quinolinium, and isoquinolinium methanides and mesoionic 1,3-oxazol-5-ones (Münchnones) 
[10], which have also been used in [2+3] cycloadditions. 
A less well-known group of stabilized azomethine ylides include mesoionic 
quinolizinium-1-olates (Scheme 1). Although a few examples have been prepared [11], they 
were only scarcely investigated in dipolar cycloadditions. For example, Pastor et al. reported 
that 1 and dimethyl acetylenedicarboxylate (DMAD) reacted already at room temperature, 
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and the [2.3.3]cyclazin-5-one derivative 23) was isolated as the only product albeit in rather 
low yield [11d]. It is important to note that the initially formed [2+3] cycloadduct could not 
be isolated and a spontaneous dehydrogenation occurred under the reaction conditions leading 
to the ‘aromatized’ product 2. Analogous reactions were observed between quinolizinium-3-
olate (3) and ethyl propiolate leading to 4 [12] and between the non-mesoionic pyrrolo[1,2-
a]pyridine (5) and DMAD in refluxing toluene in the presence of Pd/C yielding 6 [13] 
(Scheme 1).  
 
Scheme 1 
 
In the present study, we elaborated a new synthesis of 2-alkylquinolizinium-1-olates 
of type 9 and investigated their ability to undergo 1,3-dipolar cycloadditions with alkyl 
acetylene carboxylates. As the cyclazine skeleton of type 2,4,6 is familiar in the group of 
quinolizinium alkaloids [14], these cycloadditions may be of interest as a synthetic tool for 
the preparation of these products. 
 
2. Results and Discussion. – 2.1. Synthesis of 2-Alkylquinolizinium-1-olates 9. In 
analogy to the synthesis of the quinolizinium derivative 7 via cyclization of 8 by Fozard and 
Jones [11a], our approach to the betaines 9 was based on the cyclization via formation of the 
C,N-bond (Scheme 2). A suitable precursor is the aldehyde 10, which after alkylation of 11 
can be generated in situ under acidic conditions.  
 
Scheme 2 
                                                 
3) Other names for these compounds are pyrrolo[2,1,5-de]quinolizin-5-ones and 8b-
azaacenapthylen-5-one. 
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The known ketone 11 [15] was synthesized via two different routes, both including a 
Grignard reaction (Scheme 3). Starting with 2-(2-bromoethyl)-1,3-dioxolane, the Grignard 
reagent 13 was prepared at 10°, followed by dropwise addition of pyridine-2-carbaldehyde 
(12, route A). When the reaction was complete, an aqueous solution of NH4Cl was added. 
The crude alcohol was purified by column chromatography yielding 14 (29%), which was 
oxidized using MnO2 to give ketone 11 in 82% yield. In the second approach (route B), the 
mixed anhydride of 2-picolinic acid (15) and isobutylchloroformate was formed in situ, and 
subsequent treatment with N,O-dimethylhydroxylamine gave the Weinreb amide 16 [16] in 
75% yield. The following Grignard reaction with 1.5 equiv. of 13 led to 11, which was 
obtained as white crystals in 79% yield. Route A has the disadvantage of a low overall yield 
(24%), but it has to be taken into account that the higher overall yield achieved via route B 
(59%) is connected with much higher costs of the starting materials. 
 
Scheme 3 
 
The alkylation of 11 in the α-position to the C=O group was carried out by treatment 
with LDA at –78° in THF/DMPU (1,3-dimethyltetrahydropyrimidin-2(1H)-one)4), followed 
by addition of various alkyl halogenides at the same temperature, to give the desired 2-
alkylated products 17 (Table 1)5). After complete addition, the mixture was allowed to warm 
to room temperature and was then poured into ice-water. The crude products were purified by 
                                                 
4)   The yields of the alkylation were much lower in the absence of DMPU. 
5)  The temperature of the mixture had to be kept below –55°, otherwise the yields 
decreased dramatically. 
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column chromatography. With the exception of 17d, the products were obtained in good 
yields. 
 
Table 1. Formation of 17 by Alkylation of Ketone 11 and Cyclization to give 2-
Alkylquinolizinium-1-olates 9 
For the cyclization, the respective ketones 17 were dissolved in glacial AcOH and the 
solutions were heated to reflux for 12 h. Then, the excess AcOH was removed by azeotropic 
distillation with EtOH. The crude products were purified by chromatography and 
recrystallization to give 9a – 9d in 69 – 87% yield (Table 1). In the case of the allyl derivative 
17c, the 1H- and 13C-NMR spectra showed that the formed quinolizinium-1-olate 9d was the 
(E)-prop-1-enyl derivative. The structures of the products 9, which were obtained as yellow 
or orange solid materials, were determined on the basis of their analytical and spectroscopic 
data. They showed an intense UV-absorption in the range of 361 – 416 nm and a bright 
yellow fluorescence, when solutions were irradiated with UV light (λ = 366 nm). In the 13C-
NMR spectra (CDCl3), C(1)–O absorbed at 165.4 – 162.8 ppm, and the IR absorption 
(CHCl3) of the C,O group was typically found at ca. 1550 cm–1, i.e., at much lower 
frequencies than normal C=O groups6). Finally, the structure of 9a was established by means 
of X-ray crystallography (Fig. 1). The crystal structure shows that the compound has the 
expected zwitterionic character: the C(1)–O bond is significantly longer (1.272(2) Å) than 
usual for C=O groups (ca. 1.20 Å). 
 
Fig. 1. ORTEP Plot [17] of the molecular structure of 9a (arbitrary numbering of the 
atoms; 50% probability ellipsoids) 
                                                 
6)  The C(1)–O group of the analogous mesoionic 8-ethoxycarbonylacenaphtho[1,2-
b]quinolizinium-1-olate absorbs at 1586 cm–1 (KBr) [11d].  
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We also tried to prepare the known parent compound 9f [11b] via the acid-catalyzed 
cyclization of 11 under the conditions described above. The reaction was remarkably slower 
than in the previous cases, and after 40 h in refluxing glacial AcOH and chromatographic 
workup, 9f was obtained in only 10% yield. A possible explanation is the effect of a bulky 
substituent in α-position on the conformation of the intermediate for the ring closure. Such a 
substituent may promote a conformation in which the acetal group is close to the pyridine N-
atom, thereby favoring the cyclization. 
 An unexpected result was obtained with the propargyl derivative 17e. After 12 h in 
refluxing glacial AcOH, a complex mixture of products was formed. Following the progress 
of the reaction by TLC showed that a new product with a yellow fluorescence was present 
after ca. 2 h, but disappeared when the mixture was heated for a longer time. After azeotropic 
distillation of the excess AcOH with EtOH, column chromatography, and recrystallization, a 
yellow powder was isolated. Surprisingly, in the NMR-spectra, all signals of the dioxolane 
ring were still present. Additionally, the 1H-NMR spectrum showed the absorptions of a CH2 
group at 3.18 ppm (d, J = 5.2 Hz) and a Me signal at 2.63 ppm, and in the 13C-NMR 
spectrum, the signals of these groups were observed at 35.1 and 19.3 ppm. In the CI-MS 
(NH3), the [M+1]-peak appeared at m/z 246, i.e. with the same mass as the starting material 
17e. The IR spectrum showed the characteristic band at 1551 cm–1, indicating the presence of 
a quinolizinium-1-olate. On the basis of these data, the structure 9e was proposed for the 
product. 
 A reaction mechanism for the formation of 9 is proposed in Scheme 4. Under the 
acidic conditions, the dioxolane ring is opened to give intermediate A. A bulky substituent R 
may favor conformation B, which is suitable for the ring closure to give C via nucleophilic 
 8 
addition of the pyridine N-atom. Finally, elimination of ethyleneglycol and rearomatization 
yields the mesoionic product 9. 
 
Scheme 4 
 
The formation of 9c with a (E)-2-propenyl side chain can be rationalized by a 
secondary isomerization of the initially formed 1-hydroxyquinolizidinium derivative D via 
the intermediate E (Scheme 5). In the case of the propargyl derivative 17e, a protonation of 
the acetylenic group may lead to cation F, which is prone to undergo the ring closure to G. 
Aromatization of the latter via enolization and 1,3-H shift gives the isolated product 9e. It is 
important to note that the acetal unit remains unreacted under the acidic reaction conditions 
and the formal 6-endo-dig cyclization is the preferred ring closure. 
 
Scheme 5 
 
2.2. 1.3-Dipolar Cycloadditions of 9 with Acetylenes. – As shown in the introduction, 
quinoliziniumolates 1 and 3 can undergo 1,3-dipolar cycloadditions with electron-deficient 
acetylenes [11d][12]. Having in hand the quinolizinium-1-olates 9a – 9f (Table 1), we studied 
their reactions with acetylene dicarboxylates 18. For this purpose, solutions of 1 equiv. of 9 
and 2 equiv. of 18 in THF were stirred at room temperature. After ca. 30 min, 9 was 
completely consumed (TLC), and chromatographic workup gave the main product as an 
orange oil or powder (Table 2). On the basis of their analytical and spectroscopic data, the 
structure of 4-substituted [2.3.3]cyclazin-5-ones 19 (1,2-dialkoxycarbonyl-8b-
azaacenaphthylenium-5-olates) was proposed (Scheme 6). For example, the IR spectrum 
(CHCl3) of 19b showed a strong band at 1584 cm–1, and in the 13C-NMR spectrum (CDCl3), 
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the C(5)–O group absorbed at 175.2 ppm, indicating a less pronounced dipolar character 
compared with 9a. The CI-MS with [M+1]+ at m/z 376 as well as the elemental analysis 
supported this structure. Furthermore, 9a showed an intense UV absorption at 473 nm (log 
ε 4.01, MeOH) and a bright yellow fluorescence. 
  
Scheme 6 
 
Table 2. Formation of [2.3.3]Cyclazin-5-ones 19 via [2+3] Cycloaddition of  9 with 
Acetylene Dicarboxylates 18a,b 
 
The formation of the products 19 can be rationalized by a [2+3] cycloaddition of 9 and 
18 to give H, which spontaneously undergoes a dehydrogenation to yield the final product 
(Scheme 6). It is important to note that in all experiments the initially formed cycloadduct of 
type H could neither be isolated nor detected. This is in accordance with the results of the 
reaction 1 → 2 reported in [11d], whereas the reactions 3 → 4 [12] and 5 → 6 [13] (Scheme 
1) have been carried out under dehydrogenation conditions. 
For the next series of reactions with 9, unsymmetrical acetylenecarboxylates 18c – 18f 
were used. The reaction with ethyl 4,4,4-trifluorobut-2-ynoate (18c) occurred smoothly in 
THF at room temperature, yielding a single product with the characteristic spectroscopic 
properties of [2.3.3]cyclazin-5-ones of type 19 in 43% yield (Scheme 7). The exact structure 
of 19l was established by X-ray crystallography (Fig. 2b). 
 
Scheme 7 
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Fig. 2. ORTEP plots [17] of the molecular structure of 19i and 19l (arbitrary 
numbering of the atoms; 50% probability ellipsoids) 
 
The C(1)–O bond length is 1.234(3) Å and is slightly longer than a normal C=O bond 
but shorter than the C,O bond in 9a (1.272(2) Å), indicating a higher double bond character. 
On the other hand, the IR (1542 cm–1) and 13C-NMR spectra (175.8 ppm) point to a 
pronounced dipolar character of the C,O bond [18]. The molecule 19l is highly planar with all 
ring atoms being within 0.05 Å of the mean plane. The C,C double bonds are completely 
delocalized in the five-membered ring, but tend to be slightly more localized within the six-
membered rings. This is in accordance with the observation that the C(1),C(2) bond of 8b-
azaacenaphthylenium ions do not show olefinic character, i.e., they do not undergo [2+4] 
cycloadditions with, e.g., 1,3-diphenylisobenzofuran, in contrast to the isoelectronic 
acenaphthylene [12]. 
Similar to 9a, quinolizinium-1-olates 9b – 9d also reacted with 18c in THF at room 
temperature to give the corresponding products 19 in a regioselective manner (Table 3). In 
contrast, the reactions of 9a and 9b with ethyl and methyl propiolate (18d, 18e) were sluggish 
at room temperature and, therefore, were carried out in boiling toluene. After 10 – 20 h, the 
respective products of type 19 were obtained in 27 – 29%, again as a single regioisomer 
(Table 3).  
 
Table 3. Formation of [2.3.3]Cyclazin-5-ones 19 via [2+3] Cycloaddition of  9 with 
Unsymmetrical Acetylene Carboxylates 18c – 18f 
 
The product of the reaction of 9a with ethyl propiolate (18d) was obtained as dark-
yellow oil (27%), which crystallized as orange prisms after treatment with Et2O. The most 
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characteristic spectroscopic data were the IR absorption at 1577 cm–1 (CHCl3), the 13C-NMR 
signal at 174.9 ppm, and the M+ peak at m/z 331 in the EI-MS. The proposed structure 19i 
was finally established by X-ray crystallography (Fig. 2a). The molecule lies on a 
crystallographic mirror plane and is completely planar, except for the Ph ring, which is 
perpendicular to the mirror plane. The length of the C(1)–O bond is 1.241(2) Å, i.e. in the 
same range as in the case of 19l. 
Even less reactive than 18d and 18e were ethyl but-2-ynoate (18f) and butyn-3-one 
(18g). In these cases, the reactions with 9a and 9b were performed in toluene in a sealed tube 
at 140°. After ca. 60 h, the expected products 19k, 19n, and 19o were obtained in 27 – 31% 
yield (Table 3). Even under the most drastic conditions and with the most reactive acetylenes, 
no reaction of 9e leading to products of type 19 could be observed, but decomposition 
occurred. 
2.3. Formation of Side Products. – In the reactions of quinolizinium-1-olates 9 with 
acetylenes described above, the formation of minor side products was observed, in addition to 
the desired [2.3.3]cyclazin-5-ones 19. Therefore, some of the reactions were repeated aiming 
at the isolation and structure determination of some of the side products. 
Repeated chromatography of the mixture of side products of the reaction of 9a with 
18a in toluene (17 min reflux, 18 h at r.t.) gave a pure substance as a yellow oil (ca. 8%). The 
CI-MS showed the [M+1]+ peak at m/z 406, and both 1H- and 13C-NMR spectra indicated an 
adduct of 9a and 18a. Strong absorptions in the IR spectrum (CHCl3) at 1753, 1714, and 1668 
cm–1 were a sign of the presence of three C=O groups, one of them showing a 13C-NMR 
absorption at 194.4 ppm. In addition, the product was characterized by a UV absorption 
(EtOH) at 326 nm (log ε = 3.21), typical for cyclohexa-2,4-dien-1-ones [19]. On the basis of 
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these data we proposed structure 20a for this side product (Scheme 8)7). Analogous side 
products 20b – 20d were obtained from the reactions of 9a with 18b and 18d, and of 9b with 
18b. An additional side product, methyl 3-benzyl-6-(2-pyridyl)salicylate (21), could be 
isolated in the case of the reaction of 9a with 18d, whereas dimethyl 3-hydroxy-4-
methylphthalate (22) was obtained from the reaction of 9b and 18b. 
 
Scheme 8 
 
A mechanistic proposal for the formation of the identified side products is shown in 
Scheme 8. The initial reaction step is a Diels-Alder addition to yield I, which undergoes a 
spontaneous rearrangement to give the cyclohexadienone 20. In the case of R2 = H, i.e. the 
product of the reaction with methyl propiolate, a second rearrangement could lead to 3-(2-
pyridyl)salicylate 21. The mechanism of the formation of 22 is not clear, and I as well as 20 
may be the precursor. It is worth emphasizing that quinolizinium-1-olates 9 undergo [2+3] as 
well as [2+4] cycloadditions. There is only one other known example of a reaction occurring 
via similar dual pathways, which was described by McEwan et al. and by Schmitt et al. [20]. 
On treatment with HBF4, the Reissert compound 2-benzoyl-1,2-dihydroisoquinoline-1-
carbonitrile forms a reactive 1,3-oxazolium intermediate, which reacts with acetylenes and 
acrylates to give products via 1,3-dipolar cycloaddition and Diels-Alder reactions, 
respectively. On the other hand, [2+4] cycloadditions with aromatic N-heterocycles are well 
known [21], including acridizinium salts [22] and a quinolizinium salt [23]. 
2.4. Attempted 1.3-Dipolar Cycloadditions of 9 with Alkenes. – The attempted reaction 
of 9b with electron-poor alkenes like diethyl fumarate (23a), maleic anhydride, N-phenyl 
                                                 
7)  The same product 20a was formed under the usual reaction conditions (THF, r.t.; TLC 
evidence). 
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maleimide, fumaronitrile (23b), etc. in THF at room temperature failed. Even after several 
days, only starting materials could be detected (TLC). Heating of a mixture of 9b and 23a in 
toluene or mesitylene to reflux for some days led only to traces of product 19c. The initially 
formed cycloadduct could not be detected. Therefore, mixtures of 1 equiv. of 9b, 4 equiv. of 
23a or 23b, and a small amount of Pd/C in toluene were heated to reflux for 4–5 d. After 
chromatographic workup, cyclazinones 19d and 19r, respectively, were obtained in 8 and 
14% yield (Scheme 9). With other C=C dipolarophiles, no analogous products were 
formed 8).  
 
Scheme 9 
 
These results are in accordance with the observation of Alvarez-Builla that only 
acetylenes undergo the 1,3-dipolar cycloaddition with quinolizinium-1-olates, but reactions 
with alkenes and isocyanates failed [11d]. In our hands, even thiobenzophenone and 
thiofluorenone, which are known as ‘superdipolarophiles’ [24], do not undergo the 
cycloaddition with 9. 
 
3. Conclusions. – In the present work, we report on a new approach to mesoionic 
heterocycles of type 9, i.e., quinolizinium-1-olates, in reasonable yield, via a four step 
synthesis using commercially available starting materials. The key intermediate, ketone 11, 
was prepared via two different routes, both involving a Grignard reaction. The cyclization of 
the alkylated ketones 17 to give 9 was carried out under acidic conditions. In the case of the 
                                                 
8)  At a higher temperature or after a longer reaction time, only decomposition of 9b was 
observed. 
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allyl derivative, a secondary isomerization was observed, whereas an unexpected cyclization 
occurred with the propargyl derivative.  
The quinolizinium-1-olates 9 are stabilized, aromatic azomethine ylides, which 
reacted with electron poor acetylenes to give [2.3.3]cyclazin-5-ones 19 in moderate yields as 
the result of a 1,3-dipolar cycloaddition, followed by a spontaneous dehydrogenation. 
Depending on the reactivity of the acetylene, the reaction was performed in THF at room 
temperature, in boiling toluene, or at higher temperature in a sealed tube. With unsymmetrical 
acetylenes as dipolarophiles, the cycloaddition occurred regioselectively, and only one 
regioisomer was obtained.  Compared with the mesoionic 1,3-oxazol-5-ones (münchnones), 
the reactivity of 2-alkylquinolizinium-1-olates 9 is much lower. In some cases, 2,4-
cyclohexadien-1-ones 20 and phenols 21 and 22 were isolated as minor products. Their 
formation was proposed to occur via a competitive [2+4] cycloaddition (Diels-Alder reaction) 
and subsequent rearrangements. The failure of the reactions with 9e can be rationalized by 
steric hindrance of the cycloaddition step by the Me group at C(4) and by the impossibility of 
aromatization of the adduct. 
The scope of the 1,3-dipolar cycloaddition of 9 is limited to reactions with acetylenes. 
With other dipolarophiles, such as electron poor olefins or thioketones, no reaction was 
observed. Most likely, the aromatization of the initially formed cycloadducts to give 
[2.3.3]cyclazin-5-ones 19 is the driving force. Therefore, the reactions of 9 with fumaronitrile 
and ethyl fumarate as dipolarophiles, in the presence of Pd/C as dehydrating catalyst, led to 
the corresponding aromatized products, albeit in low yield.  
 
We thank Mrs. Annick Hartmann for skillful technical assistance and the analytical 
sections of our institute for spectra and analyses and the Swiss National Science Foundation 
and F. Hoffmann-La Roche AG, Basel, for financial support. 
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Experimental Part 
 
1. General. TLC: Merck 60 F254 SiO2-coated Al-plates, 0.2 mm; detection of the 
substances on the TLC plates under UV light (λ 254 nm) or with KMnO4 soln. Prep. TLC: 
Merck 60 F254 SiO2-coated glass-plates, 2 mm. Column chromatography (CC): Merck 60 
SiO2, 0.040 – 0.63 mm. M.p.: Mettler-FP-5 instrument; uncorrected. IR Spectra: Perkin-
Elmer-1600-FT-IR spectrophotometer; in CHCl3; cm–1. 1H- and 13C-NMR Spectra: Bruker-
AC-300 or Bruker-ARX-300 instrument (300 and 75.5 MHz, resp.) or Bruker-AMX 600 
instrument (600 and 150 MHz, resp.), in CDCl3; multiplicity of C-atoms from DEPT spectra. 
MS: Finnigan MAT-90 (EI, 70 eV, or CI (NH3 or isobutene)), Finnigan SSQ-700 (EI, CI), or 
Finnigan TSQ-700 (ESI) instrument. UV/VIS Spectra: Uvikon instrument; in MeOH, maxima 
in nm (log ε). Elemental analyses were performed by the Mikroanalytisches Laboratorium des 
Organisch-chemischen Instituts der Universität Zürich (Elementar Vario EL instrument).  
2. Starting Materials. All chemicals were commercially available (Fluka, Aldrich, and 
Merck). Solvents were purified as follows: hexane: distillation from CaH2; AcOEt and 
CH2Cl2: distillation from K2CO3 and stored over molecular sieves (4 Å); THF (purum, Fluka) 
and Et2O: dried over Na and distilled; toluene (p.a., Merck): stored over Na; MeOH (p.a., 
Merck) and AcOH (p.a., Merck) were directly used. 
3. Synthesis of 2-Alkylquinolizinium-1-olates 9. 3.1. Synthesis of 3-(1,3-Dioxolan-2-
yl)-1-(2-pyridyl)propan-1-on (11). Route A: 3-(1,3-Dioxolan-2-yl)-1-(2-pyridyl)propan-1-ol 
(14). In a 3-necked flask flushed with Ar and equipped with thermometer, mechanical stirrer, 
and dropping funnel, Mg pieces (2.34 g, 0.10 mol), THF (5 ml), a I2 crystal, and 2-(2-
bromoethyl)-1,3-dioxolane (2 ml) were mixed and intensively stirred. When the reaction 
started, the mixture was cooled to 10° and a soln. of 2-(2-bromoethyl)-1,3-dioxolane (12 ml, 
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0.10 mmol) in 100 ml of dry THF was added drop-wise while keeping the temperature at 10°. 
After stirring for another 0.5 h, a soln. of pyridine-2-carbaldehyde (12, 10.5 ml, 0.11 mol) in 
THF (100 ml) was added within 0.5 h. Then, the temperature was allowed to increase to r.t., 
and the mixture was stirred for 19 h. The mixture was cooled with ice, hydrolyzed by addition 
of 20% aq. NH4Cl soln. (100ml), and extracted with Et2O. The org. phase was washed with 
H2O (200 ml) and brine (100 ml), dried (MgSO4), and the solvent evaporated. The crude 
product was purified by CC (AcOEt), to give 14 (6.02 g, 29%). Yellow oil. IR (film): 3370w 
(br.), 2947m, 2912m, 2871m, 1590m, 1568m, 1470m, 1406m, 1431m, 1305w, 1211w, 1179w, 
1135s, 1105m, 1068m, 1027s, 997m, 970m, 941m, 748m, 703w. 1H-NMR: 8.53 (d, J = 4.8, 
H–C(6) Pyr); 7.68 (td, J = 7.7, 1.7, H–C(4) Pyr); 7.30 (d, J = 7.8, H–C(3) Pyr); 7.19 (dd, J = 
7.4, 5.0, H–C(5) Pyr); 4.91 (t, J = 4.4, OCHO); 4.80 (t, J = 7.0, H–C(1)); 4.38 (br. s, OH); 
3.82–3.99 (m, 4 H, OCH2CH2O); 1.97–2.04, 1.75–1.88 (2m, 2 CH2). 13C-NMR: 162.1 (s, C(2) 
Pyr); 148.2 (d, C(6) Pyr); 136.6 (d, C(4) Pyr); 122.2 (d, C(3) Pyr); 120.3 (d, C(5) Pyr); 104.3 
(d, OCHO); 72.5 (d, C(1)), 64.9, 64.8 (2t, OCH2CH2O); 32.4, 29.5 (2t, 2 CH2). CI-MS: 211 
(11), 210 (100, [M+1]+), 166 (5). 
3-(1,3-Dioxolan-2-yl)-1-(2-pyridyl)propan-1-on (11) [15]. To a soln. of 14 (6.0 g, 29 
mmol) in THF (70 ml) was added MnO2 (36 g, 414 mmol) and the mixture was heated to 
reflux for 2 h. After cooling to r.t., filtration through Celite (Et2O, 50 ml), and evaporation of 
the solvent, the product crystallized and was dried (hv). Yield of 11: 4.89 g (82%). Pale 
yellow crystals. M.p. 65.9 – 66°. IR (KBr): 3062w, 2960m, 2939m, 2873m, 1690s, 1608w, 
1580s, 1569m, 1480w, 1462m, 1439s, 1411s, 1397s, 1368s, 1354s, 1314w, 1299m, 1282s, 
1247m, 1225m, 1203m, 1175m, 1131s, 1059s, 1022s, 987s, 958s, 931s, 881s, 808m, 789m, 
760s, 704w, 663m, 612s. 1H-NMR: 8.68 (d, J = 4.8, H–C(6) Pyr); 8.03 (d, J = 7.6, H–C(3) 
Pyr); 7.83 (td, J = 7.6, 1.4, H–C(4) Pyr); 7.46 (dd, J = 7.4, 5.2, H–C(5) Pyr); 5.03 (t, J = 4.3, 
OCHO); 4.00–3.80 (m, 4 H, OCH2CH2O); 3.37 (t, J = 7.3, CH2); 2.20–2.10 (m, CH2). 13C-
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NMR: 201.1 (s, C=O); 153.4 (s, C(2) Pyr); 148.9 (d, C(6) Pyr); 136.8 (d, C(4) Pyr); 126.9 (d, 
C(5) Pyr); 121.7 (d, C(3) Pyr); 103.6 (d, OCHO); 65.0 (t, OCH2CH2O); 31.9, 28.0 (2t, 2 
CH2). CI-MS: 209 (11), 208 (100, [M+1]+). Anal. calc. for C11H13NO3 (207.22): C 63.75, H 
6.32, N 6.76; found: C 64.02, H 6.56, N 6.79. 
Route B: N-Methoxy-N-methylpyridine-2-carboxamide (16). To a suspension of 2-
picolinic acid (15, 30.78 g, 0.25 mol) in CH2Cl2 (100 ml) at 0°, N-methylmorpholine (100 ml, 
0.50 mol) was added drop-wise. Then, the clear soln. was cooled to –10°, and 
isobutylchloroformate (32.75 ml (0.25 mol) was added slowly, the mixture stirred for 0.5 h, 
and the precipitate filtered off. In another flask, N,O-dimethylhydroxylamine hydrochloride 
(24.38 g, 0.25 mol) was suspended in CH2Cl2 (100 ml), Et3N (40 ml, 0.5 mol) was added, and 
the formed Et3N.HCl was filtered off. The soln. of the amine was dropped into the soln. of the 
mixed anhydride at –10°, and the mixture was stirred until no amine was left (TLC). The 
mixture was washed with 5% aq. Na2CO3 (3 × 100 ml) and with brine (100 ml), and the org. 
phase was dried (MgSO4). The crude product was distilled (bulb-to-bulb). Yield of 16: 31.87 
g (75%). Colorless oil. IR (film): 2936m, 1658s, 1586s, 1567s, 1439s, 1415s, 1384s, 1288m, 
1226m, 1150m, 1073m, 1045m, 995s, 883w, 805m, 750s, 709m. 1H-NMR: 8.62 (d, J = 4.8, 1 
arom. H); 7.85 – 7.75 (m, 1 arom. H); 7.65 (br. s, 1 arom. H); 7.40 – 7.30 (m, 1 arom. H); 
3.75 (br. s, MeO); 3.41 (br. s, MeN). 13C-NMR: 153.0 (s, C(2) Pyr); 148.3 (d, C(6) Pyr); 
136.6 (d, C(4) Pyr); 124.7 (d, C(5) Pyr); 123.1 (d, C(3) Pyr); 61.3 (q, MeO); 33.7 (br. q, 
MeN). CI-MS: 167 (100, [M+1]+), 135 (20). 
3-(1,3-Dioxolan-2-yl)-1-(2-pyridyl)propan-1-on (11). A soln. of 16 (16.6 g, 0.10 mol) 
in dry THF (120 ml) was cooled to –5°, and 1.5 equiv. of the Grignard reagent 13 were added 
drop-wise. After complete addition, the mixture was stirred for 2 h at 0° and then hydrolyzed 
by addition of 3% HCl in EtOH (100 ml) at 0°. The mixture was poured into a mixture of 
brine and Et2O/CH2Cl2 (1:1), the org. phase was separated and dried (MgSO4), and the 
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solvent evaporated. Yield of 11: 16.35 g (79%). 
3.2. Alkylation of 11 to 2-Alkyl-3-(1,3-dioxolan-2-yl)-1-(2-pyridyl)propan-1-ones 17. 
2-Benzyl-3-(1,3-dioxolan-2-yl)-1-(2-pyridyl)propan-1-one (17a). A soln. of LDA (37 ml, 1.5 
M, 56 mmol) in dry THF (150 ml) was cooled to –78°, and a mixture of 11 (4.87 g, 23.5 
mmol), dissolved in 1,3-dimethyltetrahydropyrimidin-2(1H)-one (DMPU, 48.7 ml) was 
added, keeping the temp. below –55°. The mixture was stirred for 2 – 3 h, and a soln. of 
benzyl bromide (3 ml, 17.8 mmol) in THF (40 ml) was added. The mixture was allowed to 
reach r.t. slowly and was stirred for 40 h. Then, H2O (10 ml) was added and the mixture was 
poured into ice water, extracted with Et2O (3 × 100 ml), dried (MgSO4), and evaporated. The 
crude product was separated by CC (hexane/AcOEt 4:1). Yield of 17a: 4.4 g (64%). 
Brownish oil. IR (film): 3055w, 3021w, 2920m, 2880m, 1690s, 1599w, 1580m, 1563w, 
1491w, 1450m, 1432m, 1366m, 1227m, 1135s, 1024m, 992s, 975s, 943m, 877w, 850w, 793m, 
746s, 698s, 616s. 1H-NMR: 8.65 (d, J = 4.7, H–C(6) Pyr); 8.00 (d, J = 7.6, H–C(3) Pyr); 7.76 
(td, J = 7.6, 1.5, H–C(4) Pyr); 7.35 (ddd, J = 7.4, 4.5, 1.2, H–C(5) Pyr); 7.30–7.00 (m, 5 arom. 
H); 4.87 (t, J = 4.3, OCHO); 4.75–4.60 (m, H–C(2)); 3.90–3.51 (m, 4 H, OCH2CH2O); 3.10 
(dd, J = 13.6, 6.6, Ha of PhCH2); 2.75 (dd, J = 13.6, 8.2, Hb of PhCH2); 2.35 (ddd, J = 14.2, 
9.8, 4.4, Ha–C(3)); 1.90 (dt, J = 14.0, 3.9, Hb–C(3)). 13C-NMR: 203.7 (s, C=O); 153.3 (s, C(2) 
Pyr); 148.8 (d, C(6) Pyr); 139.3 (s, C(1) Ph); 136.7 (d, C(4) Pyr); 129.2, 128.2 (2d, 4 arom. 
CH); 126.7 (d, C(5) Pyr); 126.1 (d, 1 arom. CH); 122.3 (d, C(3) Pyr); 103.0 (d, OCHO); 64.8, 
64.6 (2t, OCH2CH2O); 40.9 (d, C(2)); 38.4 (t, PhCH2); 34.9 (t, C(3)). CI-MS: 299 (15), 298 
(100, [M+1]+). Anal. calc. for C18H19NO3 (297.34): C 72.71, H 6.44, N 4.71; found: C 72.68, 
H 6.59, N 4.88. 
2-Methyl-3-(1,3-dioxolan-2-yl)-1-(2-pyridyl)propan-1-one (17b). In analogy to the 
preparation of 17a: LDA (56 ml, 2 M, 112 mmol) in THF (150 ml), 11 (9.74 g, 47 mmol) in 
DMPU (97.4 ml), MeI (24 ml, 400 mmol) in THF (60 ml), 20 h. Yield of 17b: 5.70 g (55%). 
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Brownish oil. IR (film): 3054w, 2969m, 2880m, 1697s, 1582m, 1568m, 1459m, 1435m, 
1353m, 1266m, 1228m, 1143s, 1029s, 984s, 809m, 748m, 701m, 664w. 1H-NMR: 8.69 (d, J = 
4.2, H–C(6) Pyr); 8.05 (d, J = 7.5, H–C(3) Pyr); 7.83 (td, J = 7.6, 1.5, H–C(4) Pyr); 7.45 
(ddd, J = 7.6, 4.5, 1.3, H–C(5) Pyr); 4.95 (t, J = 4.9, OCHO); 4.40–4.30 (m, H–C(2)); 4.00–
3.70 (m, 4 H, OCH2CH2O); 2.36 (ddd, J = 14.0, 9.4, 4.6, Ha–C(3)); 1.96 (dt, J = 14.0, 4.6, 
Hb–C(3)); 1.24 (d, J =6.9, Me). 13C-NMR: 204.5 (s, C=O); 152.9 (s, C(2) Pyr); 148.8 (d, C(6) 
Pyr); 136.7 (d, C(4) Pyr); 126.7 (d, C(5) Pyr); 122.3 (d, C(3) Pyr); 103.0 (d, OCHO); 64.7, 
64.6 (2t, OCH2CH2O); 36.9 (t, C(3)); 34.3 (d, C(2)); 17.8 (q, Me). CI-MS: 223 (12), 222 
(100, [M+1]+), 208 (5). Anal. calc. for C12H15NO3 (221.26): C 65.14, H 6.83; found: C 65.46, 
H 6.83. 
2-Allyl-3-(1,3-dioxolan-2-yl)-1-(2-pyridyl)propan-1-one (17c). In analogy to the 
preparation of 17a: LDA (28 ml, 2 M, 56 mmol) in THF (100 ml), 11 (4.87 g, 23.5 mmol) in 
DMPU (48.7 ml), allyl bromide (10 ml, 100 mmol) in THF (40 ml), 25 h. Yield of 17c: 3.71 g 
(64%). Brown oil. IR (film): 2943m, 1668s, 1495s, 1446s, 1375s, 1285s, 1214m, 1132s, 
1084m, 995m, 759m, 665w. 1H-NMR: 8.69 (d, J = 3.7, H–C(6) Pyr); 8.04 (d, J = 7.2, H–C(3) 
Pyr); 7.82 (td, J = 7.6, 1.5, H–C(4) Pyr); 7.45 (ddd, J = 7.5, 4.5, 1.3, H–C(5) Pyr); 5.83–5.60 
(m, CH2=CH); 5.04, 4.99 (2d, J = 1.5, CH2=CH); 4.92 (t, J = 4.4, OCHO); 4.50–4.40 (m, H–
C(2)); 3.90–3.60 (m, 4 H, OCH2CH2O); 2.57–2.47 (m, Ha of CH2=CH-CH2); 2.40–2.16 (m, 
Hb of CH2=CH–CH2), Ha–C(3)); 1.94 (dt, J = 14.0, 4.0, Hb–C(3)). 13C-NMR: 203.7 (s, C=O); 
153.4 (s, C(2) Pyr); 148.8 (d, C(6) Pyr); 136.8 (d, C(4) Pyr); 135.5 (d, CH2=CH); 126.8 (d, 
C(5) Pyr); 122.3 (d, C(3) Pyr); 116.9 (t, CH2=CH); 103.0 (d, OCHO); 64.9, 64.7 (2t, 
OCH2CH2O); 38.7 (d, C(2)); 36.8 (t, CH2=CH–CH2); 35.0 (t, C(3)). CI-MS: 249 (59), 248 
(100, [M+1]+), 208 (22), 129 (23). Anal. calc. for C14H17NO3 (247.29): C 68.00, H 6.93, N 
5.66; found: C 68.29, H 7.06, N 5.73. 
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2-Isopropyl-3-(1,3-dioxolan-2-yl)-1-(2-pyridyl)propan-1-ons (17d). In analogy to the 
preparation of 17a: LDA (28 ml, 2 M, 56 mmol) in THF (100 ml), 11 (4.87 g, 23.5 mmol) in 
DMPU (48.7 ml), isopropyl iodide (15 ml, 150 mmol) in THF (40 ml), 42 h. Yield of 17d: 
1.04 g (18%). Brownish oil. IR (Film): 3054w, 2962s, 2876s, 1732m, 1693s, 1582s, 1568m, 
1465s, 1435s, 1388s, 1371s, 1223s, 1140s, 1045s, 994s, 979s, 871m, 789m, 694m, 676m. 1H-
NMR: 8.69 (d, J = 4.4, H–C(6) Pyr); 8.06 (d, J = 7.7, H–C(3) Pyr); 7.82 (td, J = 7.6, 1.5, H–
C(4) Pyr); 7.42 (ddd, J = 7.5, 4.5, 1.3, H–C(5) Pyr); 4.88 (t, J = 4.1, OCHO); 4.28–4.20 (m, 
H–C(2)); 3.70–3.50 (m, 4 H, OCH2CH2O); 2.40 (ddd, J = 13.9, 11.3, 4.0, Ha–C(3)); 2.04 
(sept., J = 6.7, Me2CH); 1.90 (dt, J = 13.8, 3.8, Hb C(3)); 0.95, 0.89 (2d, J = 6.8, Me2CH). 
13C-NMR: 204.4 (s, C=O); 154.1 (s, C(2) Pyr); 148.8 (d, C(6) Pyr); 136.8 (d, C(4) Pyr); 126.5 
(d, C(5) Pyr); 122.2 (d, C(3) Pyr); 103.4 (d, OCHO); 64.9, 64.7 (2t, OCH2CH2O); 44.3 (d, 
C(2)); 32.4 (t, C(3)); 30.5 (d, Me2CH); 20.9, 19.3 (2q, Me2CH). CI-MS: 251 (19), 250 (100, 
[M+1]+). Anal. calc. for C14H19NO3 (249.31): C 67.45, H 7.68, N 5.62; found: C 67.81, H 
7.60, N 5.49. 
2-Propargyl-3-(1,3-dioxolan-2-yl)-1-(2-pyridyl)propan-1-one (17e). In analogy to the 
preparation of 17a: LDA (12 ml, 2 M, 24 mmol) in THF (100 ml), 11 (2.0 g, 10 mmol) in 
DMPU (20 ml), propargyl bromide (7.4 ml, 11.4 mmol) in THF (25 ml), 20 h. Yield of 17e: 
1.50 g (64%). Brown oil. IR (Film): 3280m, 3054w, 2887m, 2117w, 1697s, 1583s, 1568m, 
1465m, 1436s, 1368s, 1269m, 1221m, 1140s, 1025s, 995s, 981s, 945m, 803m, 746m. 1H-
NMR: 8.68 (d, J = 4.8, H–C(6) Pyr); 8.06 (d, J = 7.8, H–C(3) Pyr); 7.84 (td, J = 7.7, 1.8, H–
C(4) Pyr); 7.46 (ddd, J = 7.5, 4.8, 1.3, H–C(5) Pyr); 4.97 (t, J = 4.2, OCHO); 4.51–4.43 (m, 
H–C(2)); 3.90–3.65 (m, 4 H, OCH2CH2O); 2.70–2.58 (m, HC≡C–CH2); 2.41 (ddd, J = 14.3, 
8.9, 4.3, Ha–C(3)); 2.14 (dt, J = 14.3, 4.5, Hb–C(3)); 1.95 (t, J = 2.7, HC≡). 13C-NMR: 201.8 
(s, C=O); 152.8 (s, C(2) Pyr); 148.7 (d, C(6) Pyr); 136.8 (d, C(4) Pyr); 126.8 (d, C(5) Pyr); 
122.3 (d, C(3) Pyr); 102.7 (d, OCHO); 81.5 (s, HC≡C); 70.0 (d, HC≡C); 64.8, 64.5 (2t, 
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OCH2CH2O); 38.7 (d, C(2)); 33.9 (t, C(3)); 21.2 (t, HC≡C-CH2). CI-MS: 247 (14), 246 (100, 
[M+1]+), 208 (7), 168 (6), 140 (20), 136 (7). Anal. calc. for C14H15NO3 (245.28): C 68.56, H 
6.16, N 5.71; found: C 68.33, H 6.16, N 5.52. 
3.3. Cyclization of 17 to 2-Alkylquinolizinium-1-olates 9. 2-Benzylquinolizinium-1-
olate (9a). A soln. of 17a (4.40 g, 14.8 mmol) in glacial AcOH (130 ml) was heated to reflux 
for 12 h. The excess AcOH was removed by azeotropic distillation with EtOH, and the 
residue was purified by CC (CH2Cl2/MeOH 12:1) and the product dried (hv, 80°). Yield of 
9a: 3.01 g (87%). Yellow powder. Recrystallization from EtOH/Et2O gave yellow crystals, 
m.p.159–160°. UV (MeOH): 393 (3.65). IR (CHCl3): 2960m, 1551s, 1512m, 1477s, 1462s, 
1420w, 1356w, 1331m, 1310w, 1260w, 1187w, 1160w, 1136w, 1097w, 1026w, 698w, 659w. 
1H-NMR: 8.73 (d, J = 8.7, 1 arom. H); 8.22 (d, J = 6.8, 1 arom. H); 7.54 (d, J = 6.3, 1 arom. 
H); 7.40–7.16 (m, 7 arom. H); 7.12 (d, J = 6.3, 1 arom. H); 4.17 (s, PhCH2). 13C-NMR: 164.1 
(s, C(1)); 140.2, 138.1, 134.5 (3s, C(2), C(9a), C(1) Ph); 131.8, 129.4, 128.5, 126.2, 126.1, 
125.5, 125.4, 121.4, 114.3 (9d, C(3)–C(9), 5 CH Ph); 36.1 (t, PhCH2). CI-MS: 237 (19), 236 
(100, [M+1]+). Anal. calc. for C16H13NO (235.27): C 81.68, H 5.57, N 5.59; found: C 81.35, 
H 5.51, N 5.81. 
Suitable crystals of 9a for the X-ray crystal-structure determination were obtained by 
crystallization from THF/hexane.  
2-Methylquinolizinium-1-olate (9b). In analogy to the preparation of 9a: 17b (5.70 g, 
25.7 mmol) in glacial AcOH (140 ml), 10 h. Yield of 9b: 3.54 g (86%). Yellow crystals. M.p. 
149–150° (EtOH/Et2O). UV (MeOH): 361 (3.86). IR (CHCl3): 2966w, 2476w, 1763w, 
1601w, 1555s, 1516m, 1478s, 1464s, 1417m, 1376m, 1349m, 1322s, 1269m, 1160m, 1141w, 
1099w, 1050w, 1026w, 932w, 881w, 658m. 1H-NMR: 8.69 (d, J = 8.7, 1 arom. H); 8.13 (d, J 
= 6.8, 1 arom. H); 7.48 (d, J = 6.1, 1 arom. H); 7.40–7.20 (m, 3 arom. H); 2.39 (s, Me). 13C-
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NMR: 165.4 (s, C(1)); 132.1, 131.4 (2s, C(2), C(9a)); 126.4, 125.6, 125.4, 121.1, 113.4 (5d, 
C(3)–C(9)); 17.2 (q, Me). ESI-MS: 181 (20), 160 (100, [M+1]+). 
2-(Prop-1-enyl)quinolizinium-1-olate (9c). In analogy to the preparation of 9a: 17c 
(4.80 g, 19.4 mmol) in glacial AcOH (140 ml), 12 h. Yield of 9c: 2.50 g (69%). Yellow 
crystals. M.p. 129–130° (EtOH/Et2O). UV (MeOH): 416 (4.05). IR (CHCl3): 2964m, 1760w, 
1549s, 1409m, 1470s, 1456s, 1422m, 1358m, 1328s, 1261s, 1139m, 1099m, 1026m, 813m, 
658m. 1H-NMR: 8.68 (d, J = 8.7, 1 arom. H); 8.18 (d, J = 6.8, 1 arom. H); 7.47 (d, J = 6.5, 1 
arom. H); 7.40–7.15 (m, 3 arom. H); 6.95–6.73 (m, CH=CH); 1.94 (d, J = 5.4, Me). 13C-
NMR: 163.4 (s, C(1)); 139.1, 128.3 (2s, C(2), C(9a)); 132.0, 128.7, 126.6, 126.3, 125.4, 
122.0, 120.9, 114.0 (8d, C(3)–C(9), CH=CH); 19.2 (q, Me). CI-MS: 186 (100, [M+1]+), 170 
(7). 
2-Isopropylquinolizinium-1-olate (9d). In analogy to the preparation of 9a: 17d (1.0 g, 
4.0 mmol) in glacial AcOH (75 ml), 12 h. Yield of 9d: 0.52 g (70%). Yellow crystals. M.p. 
139–140° (EtOH/Et2O). IR (CHCl3): 2965m, 2872m, 2479w, 2361w, 1764s, 1639m, 1548s, 
1512m, 1457s, 1421s, 1368s, 1337s, 1308s, 1288m, 1262s, 1164s, 1099s, 1014s, 924m, 894m, 
867m, 806s, 658m, 629m. 1H-NMR: 8.75 (d, J = 8.7, 1 arom. H); 8.11 (d, J = 6.8, 1 arom. H); 
7.51 (d, J = 8.7, 1 arom. H); 7.4-7.3 (m, 2 arom. H); 7.25-7.20 (m, 1 arom. H); 3.68 (sept., J = 
6.9, Me2CH); 1.27 (d, J = 6.9, Me2CH). 13C-NMR: 162.8 (s, C(1)); 141.7, 137.5 (2s, C(2), 
C(9a)); 131.9, 126.3, 125.1, 124.3, 121.1, 115.5 (6d, C(3)–C(9)); 26.7 (d, Me2CH); 21.7 (q, 
Me2CH). CI-MS: 189 (13), 188 (100, [M+1]+). 
2-[(1,3-Dioxolan-2-yl)methyl]-4-methylquinolizinium-1-olate (9e). In analogy to the 
preparation of 9a: 17e (1.5 g, 6.1 mmol) in glacial AcOH (80 ml), 2.5 h. Yield of 9e: 0.30 g 
(21%). Yellow powder. IR (CHCl3): 2963m, 1691w, 1612w, 1551s, 1508w, 1476m, 1448m, 
1415m, 1327w, 1307w, 1261s, 1099s, 1013s, 806s, 658w. 1H-NMR: 8.83–8.79 (m, 1 arom. 
H); 8.21–8.18 (m, 1 arom. H); 7.50–7.42 (m, 2 arom. H); 7.41 (s, H–C(3)); 5.31 (t, J = 5.2, 
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OCHO); 4.10–3.70 (m, 4 H, OCH2CH2O); 3.18 (d, J = 5.2, CH2); 2.63 (s, Me). 13C-NMR: 
163.6 (s, C(1)); 138.3, 129.1 (2s, C(2), C(9a)); 128.8, 127.5, 125.6, 125.3, 121.9 (5d, C(3), 
C(5)–C(9)); 120.1 (s, C(4)); 102.4 (d, OCHO); 64.7, 64.5 (2t, OCH2CH2O); 35.1 (t, CH2); 
19.3 (q, Me). CI-MS: 278 (9), 262 (38, [M+NH3]+), 247 (14), 246 (100, [M+1]+). 
Quinolizinium-1-olate (9f) [11b]. In analogy to the preparation of 9a: 11 (1.0 g, 4.8 
mmol) in glacial AcOH (75 ml), 40 h. Yield of 9f: 70 mg (10%). Brownish powder. M.p. 
183–184°. IR (CHCl3): 2924m, 2852m, 1568s, 1500m, 1471m, 1448m, 1453m, 1352w, 
1310w, 1162w, 899w, 700w, 658w. 1H-NMR: 8.69 (d, J = 8.6, 1 arom. H); 8.14 (d, J = 6.8, 1 
arom. H); 7.39–7.44 (m, 2 arom. H); 7.29–7.33 (m, 2 arom. H); 6.96 (d, J = 8.7, 1 arom. H). 
13C-NMR: 163.9 (s, C(1)); 136.9 (s, C(9a)); 133.0, 128.1, 125.7, 124.4, 122.2, 118.9, 116.3 
(7d, C(2)–C(9)). CI-MS: 147 (8), 146 (100, [M+1]+). 
4. [2+3] Cycloadditions of 9 with Acetylenes. General Procedures. General 
Procedure A (GPA). To a soln. of 1 equiv. of 9 in abs. THF (10 ml) under a N2 atmosphere, 
the respective acetylene derivative 18 (2 equiv.) was added, and the mixture was stirred at r.t. 
until 9 was consumed (TLC). The crude products were purified by CC (hexane/AcOEt 4:1 or 
2:1) and, if necessary, followed by prep. TLC (hexane/AcOEt 1:1). 
General Procedure B (GPB). In toluene (10 ml) under a N2 atmosphere, 1 equiv. of 9 
was suspended (sonification), and the respective acetylene 18 (2 equiv.) was added at r.t. 
Then, the mixture was heated to reflux until 9 was consumed. The crude products were 
purified by CC (hexane/AcOEt 4:1 or 2:1) and, if necessary, followed by prep. TLC 
(hexane/AcOEt 1:1). 
General Procedure C (GPC). A mixture of 9 (1 equiv.), 18 (2 equiv.), and toluene (3–
5 ml) in an evacuated and sealed tube was heated to 140° for 50–60 h. The crude products 
were purified by CC (hexane/AcOEt 4:1 or 2:1) and, if necessary, followed by prep. TLC 
(hexane/AcOEt 1:1). 
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4-Benzyl-1,2-di(ethoxycarbonyl)-8b-azaacenaphthylenium-5-olate (19a). GPA; 9a 
(120 mg, 0.51 mmol), diethyl acetylenedicarboxylate (18a, 176 mg, 1.03 mmol). Yield of 
19a: 76 mg (36%). Orange oil. IR (CHCl3): 3001m, 2925m, 2854w, 1725s, 1710s, 1633m, 
1582s, 1498m, 1474s, 1408m, 1383m, 1304s, 1273s, 1239s, 1215s, 1182m, 1143m, 1082s, 
1051w, 1022m, 856w, 810w, 699w. 1H-NMR: 8.76 (d, J = 8.6, H–C(6/8)); 8.55 (d, J = 7.6, H–
C(8/6)); 7.93 (s, H–C(3)); 7.86 (t, J = 8.1, H–C(7)); 7.16–7.28 (m, 5 arom. H); 4.43–4.34 (m, 
4 H, 2 MeCH2O); 4.05 (s, PhCH2); 1.37, 1.27 (2t, J = 7.1, 2 MeCH2O). 13C-NMR: 175.2 (s, 
C(5)); 163.5, 163.0 (2s, 2 EtO2C); 139.0, 138.6, 136.0, 132.0 (4s, C(4), C(5a), C(8a), C(1) 
Ph); 129.4, 128.7, 127.4, 126.6, 126.5, 124.6, 119.2 (7d, C(3), C(6), C(7), C(8), 5 CH Ph); 
124.9, 119.8, 111.0 (3s, C(1), C(2), C(2a)); 62.0, 61.1 (2t, 2 MeCH2O); 36.2 (t, CH2Ph); 14.3, 
14.1 (2q, 2 MeCH2O). CI-MS: 405 (24), 404 (100, [M+1]+), 298 (21). 
4-Benzyl-1,2-di(methoxycarbonyl)-8b-azaacenaphthylenium-5-olate (19b). GPA; 9a 
(120 mg, 0.51 mmol), dimethyl acetylenedicarboxylate (18b, 150 mg, 1.06 mmol). Yield of 
19b: 96 mg (40%). Orange powder. M.p. 169–170°. UV (MeOH): 473 (4.01). IR (CHCl3): 
3000w, 2954w, 1713s, 1636w, 1584s, 1499m, 1473m, 1442m, 1396w, 1307s, 1274s, 1240s, 
1216s, 1177m, 1143m, 1087s, 1052w, 1000w, 940, 809w, 700w. 1H-NMR: 8.79 (d, J = 8.3, 
H–C(6/8)); 8.59 (d, J = 7.5, H–C(8/6)); 8.05 (s,  H–C(3)); 7.91 (t, J = 8.2, H–C(7)); 7.37–7.23 
(m, 5 arom. H); 4.11 (s, PhCH2); 4.00 (s, 2 MeO). 13C-NMR: 175.2 (s, C(5)); 164.0, 163.4 
(2s, 2 MeO2C); 139.1, 138.7, 135.9, 132.1 (4s, C(4), C(5a), C(8a), C(1) Ph); 129.3, 128.6, 
127.4, 126.5, 124.5, 119.9 (6d, C(3), C(6), C(7), C(8), 5 CH Ph); 126.6, 124.4, 110.6 (3s, 
C(1), C(2), C(2a)); 52.6, 52.2 (2q, 2 MeO); 36.3 (t, PhCH2). CI-MS: 377 (24), 376 (100, 
[M+1]+), 362 (17), 288 (30). Anal. calc. for C22H17NO5 (375.38): C 70.39, H 4.56, N 3.73; 
found: C 70.07, H 4.61, N 3.59. 
4-Methyl-1,2-di(ethoxycarbonyl)-8b-azaacenaphthylenium-5-olate (19c). GPA; 9b 
(160 mg, 1.0 mmol), 18a (349 mg, 2.05 mmol). Yield of 19c: 96 mg (29%). Orange oil. IR 
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(CHCl3): 3026m, 2986m, 1727s, 1638m, 1585m, 1501m, 1475m, 1444m, 1410m, 1377m, 
1277s, 1241s, 1210w, 1191m, 1194m, 1089s, 1022s, 860w, 813w, 674m. 1H-NMR: 8.77 (dd, J 
= 8.6, 0.9, H–C(6/8)); 8.55 (dd, J = 7.7, 1.0, H–C(8/6)); 8.15 (d-like, J = 0.9, H–C(3)); 7.86 
(t, J = 7.9, H–C(7)); 4.47, 4.41 (2q, J = 7.2, 2 MeCH2O); 2.33 (d, J = 0.9, Me); 1.41–1.38 (2t, 
J = 7.2, 2 MeCH2O). 13C-NMR: 175.8 (s, C(5)); 163.9, 163.0 (2s, 2 EtO2C); 135.9, 135.7, 
131.4 (3s, C(4), C(5a), C(8a)); 127.3, 126.3, 124.4, 119.6 (4d, C(3), C(6), C(7), C(8)); 123.2, 
118.5, 110.6 (3s, C(1), C(2), C(2a)); 62.1, 61.1 (2t, 2 MeCH2O); 17.0 (q, Me); 14.4, 14.3 (2q, 
2 MeCH2O). EI-MS: 328 (19), 327 (100, M+), 299 (9), 282 (12), 255 (10), 254 (22), 227 (14), 
182 (12). 
4-Methyl-1,2-di(methoxycarbonyl)-8b-azaacenaphthylenium-5-olate (19d). GPA; 9b 
(164 mg, 1.03 mmol), 18b (286 mg, 2.00 mmol). Yield of 19d: 117 mg (39%). Orange 
powder. M.p. 148–149°. IR (CHCl3): 3030w, 3007w, 2955m, 1734s, 1636s, 1586s, 1499m, 
1444m, 1396w, 1377w, 1300s, 1278s, 1243s, 1198m, 1179m, 1162m, 1143m, 1091m, 1021w, 
1003w, 943w, 832w, 667m. 1H-NMR: 8.60 (dd, J = 8.6, 0.9, H–C(6/8)); 8.38 (dd, J = 7.5, 1.0, 
H–C(8/6)); 8.06 (d-like, J = 0.9, H–C(3)); 7.78 (t, J = 7.7, H–C(7)); 4.06, 3.99 (2s, 2 MeO); 
2.31 (d, J = 0.7, Me). 13C-NMR: 175.5 (s, C(5)); 163.9, 163.2 (2s, 2 MeO2C); 135.9, 135.3, 
131.1 (3s, C(4), C(5a), C(8a)); 127.1, 126.3, 124.2, 119.6 (4d, C(3), C(6), C(7), C(8)); 123.5, 
119.6, 110.1 (3s, C(1), C(2), C(2a)); 52.9, 52.4 (2q, 2 MeO); 16.9 (q, Me). EI-MS: 300 (17), 
299 (100, M+), 285 (13), 284 (26), 268 (40), 254 (25), 253 (16), 252 (22), 238 (13), 182 (15), 
181 (10), 167 (50), 113 (9), 43 (19). Anal. calc. for C16H13NO5 (299.28): C 64.21, H 4.38, N 
4.68; found: C 63.97, H 4.29, N 4.43. 
4-(Prop-1-enyl)-1,2-di(methoxycarbonyl)-8b-azaacenaphthylenium-5-olate (19e). 
GPA; 9c (186 mg, 1.0 mmol), 18b (279 mg, 1.96 mmol). Yield of 19d: 108 mg (33%). 
Orange oil. IR (CHCl3): 3008m, 2956m, 1730s, 1640m, 1591s, 1501m, 1476m, 1437m, 
1396m, 1084m. 1H-NMR: 8.72 (dd, J = 8.6, 1.0, H–C(6/8)); 8.55 (dd, J = 7.6, 1.1, H–C(8/6)); 
 26 
8.20 (s, H–C(3)); 7.87 (t, J = 7.6, H–C(7)); 6.85–6.70 (m, CH=CH); 4.08, 4.00 (2s, 2 MeO); 
1.98 (d, J = 5.3, Me). 13C-NMR: 174.2 (s, C(5)); 164.2, 163.3 (2s, 2 MeO2C); 135.9, 133.7, 
132.5 (3s, C(4), C(5a), C(8a)); 131.1, 126.6, 125.0, 124.5, 123.5, 120.1 (6d, C(3), C(6), C(7), 
C(8), CH=CH); 124.3, 119.6, 110.1 (3s, C(1), C(2), C(2a)); 52.9, 52.1 (2q, 2 MeO); 16.9 (q, 
Me). CI-MS: 327 (17), 326 (100, [M+1]+). 
4-Isopropyl-1,2-di(methoxycarbonyl)-8b-azaacenaphthylenium-5-olate (19f). GPA; 
9d (97 mg, 0.51 mmol), 18b (158 mg, 1.11 mmol). Yield of 19f: 68 mg (41%). Orange oil. IR 
(CHCl3): 2994m, 2956m, 2872m, 1712s, 1637s, 1590s, 1495m, 1465m, 1397m, 1368m, 
1354m, 1317s, 1148s, 1107m, 999m, 978m, 859m. 1H-NMR: 8.79 (dd, J = 8.6, 1.0, H–
C(6/8)); 8.59 (dd, J = 7.6, 1.1, H–C(8/6)); 8.13 (s, H–C(3)); 7.91 (t, J = 7.7, H–C(7)); 4.09, 
4.02 (2s, 2 MeO); 3.52 (sept., J = 6.8, Me2CH); 1.32 (d, J = 6.9, Me2CH). 13C-NMR: 175.2 (s, 
C(5)); 164.5, 163.5 (2s, 2 MeO2C); 145.9, 135.7, 132.0 (3s, C(4), C(5a), C(8a)); 126.4, 124.4, 
124.1, 119.8 (4d, C(3), C(6), C(7), C(8)); 120.0, 110.1 (2s, C(1), C(2), C(2a)); 53.0, 52.1 (2q, 
2 MeO); 27.5 (d, Me2CH); 21.6 (q, Me2CH). CI-MS: 330 (5), 329 (19), 328 (100, [M+1]+), 
314 (17), 288 (9), 232 (5). Anal. calc. for C18H17NO5 (327.34): C 66.05, H 5.23, N 4.28; 
found: C 65.74, H 5.18, N 4.46. 
1,2-Di(methoxycarbonyl)-8b-azaacenaphthylenium-5-olate (19g). GPA; 9f (70 mg, 
0.48 mmol), 18b (76 mg, 0.55 mmol). Yield of 19g: 24 mg (19%). Orange oil. IR (KBr): 
3072w, 2953m, 2924m, 2853m, 1719s, 1649m, 1606m, 1501m, 1468m, 1439m, 1395m, 
1353m, 1344m, 1316m, 1277s, 1247s, 1149m, 1132m, 1096m, 1070m, 995m, 922w, 872w, 
841w, 806m, 761w, 725w, 710w. 1H-NMR: 8.85 (d, J = 8.6, H–C(6/8)); 8.60 (d, J = 7.6, H–
C(8/6)); 8.30 (d, J = 9.9, H–C(3)); 7.97 (t, J = 8.1, H–C(7)); 7.16 (d, J = 9.9, H–C(4)); 4.07, 
4.02 (2s, 2 MeO). 13C-NMR: 176.1 (s, C(5)); 163.9, 163.3 (2s, 2 MeO2C); 136.4, 133.3 (2s, 
C(5a), C(8a)); 130.0, 127.2, 126.2, 125.0, 119.9 (5d, C(3), C(4), C(6), C(7), C(8)); 125.1, 
120.2, 111.2 (3s, C(1), C(2), C(2a)); 53.0, 52.3 (2q, 2 MeO). CI-MS: 286 (100, [M+1]+). 
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4-Benzyl-1-ethoxycarbonyl-2-trifluoromethyl-8b-azaacenaphthylenium-5-olate (19h). 
GPA; 9a (59 mg, 0.25 mmol), ethyl 4,4,4-trifluorobut-2-ynoate (18c, 87 mg, 0.51 mmol). 
Yield of 19h: 43 mg (43%). Orange oil. IR (CHCl3): 3026w, 2962m, 2928m, 1738s, 1639m, 
1593s, 1504w, 1475m, 1410m, 1386m, 1311m, 1261s, 1236s, 1151m, 1127m, 1085s, 1019m, 
809m, 699w. 1H-NMR: 9.00 (dd, J = 8.7, 0.9, H–C(6/8)); 8.64 (dd, J = 7.5, 1.0, H–C(8/6)); 
8.14 (s, H–C(3)); 7.96 (t, J = 7.7, H–C(7)); 7.40–7.21 (m, 5 arom. H); 4.49 (q, J = 7.1, 
MeCH2O); 4.12 (s, PhCH2); 1.47 (t, J = 7.1, MeCH2O). CI-MS: 401 (18), 400 (100, [M+1]+). 
4-Benzyl-1-ethoxycarbonyl-8b-azaacenaphthylenium-5-olate (19i). GPB; 9a (120 mg, 
0.51 mmol), ethyl propiolate (18d, 101 mg, 1.03 mmol). Yield of 19i: 41 mg (24%). Yellow-
orange powder. M.p. 140.3–141°. IR (CHCl3): 3000m, 1700s, 1634w, 1577s, 1529m, 1513m, 
1492w, 1450m, 1417m, 1384m, 1335w, 1304s, 1237s, 1220s, 1175w, 1149s, 1116m, 1074s, 
1028w, 1017w, 960w, 915w, 863w, 810w, 699w, 658w. 1H-NMR: 8.79 (dd, J = 8.4, 0.9, H–
C(6/8)); 8.57 (dd, J = 7.7, 0.8, H–C(8/6)); 7.87 (t, J = 8.0, H–C(7)); 7.84, 7.72 (2s, H–C(2), 
H–C(3)); 7.29–7.17 (m, 5 arom. H); 4.39 (q, J = 7.1, MeCH2O); 4.06 (s, PhCH2); 1.38 (t, J = 
7.1, MeCH2O). 13C-NMR: 174.9 (s, C(5)); 163.8 (s, EtO2C); 139.0, 137.6, 136.9, 132.2 (4s, 
C(4), C(5a), C(8a), C(1) Ph); 129.4, 128.2, 126.4, 125.9, 123.2, 122.2, 118.7 (7d, C(2), C(3), 
C(6), C(7), C(8), 5 CH Ph); 120.2, 112.7 (2s, C(1), C(2a)); 60.5 (t, MeCH2O); 36.0 (t, 
PhCH2); 14.4 (q, MeCH2O). EI-MS: 332 (23), 331 (100, M+•), 330 (27), 303 (10), 302 (38), 
286 (20), 258 (29), 257 (13), 228 (8), 169 (17), 69 (10). Anal. calc. for C21H17NO3 (331.38): 
C 76.11, H 5.17, N 4.23; found: C 75.77, H 5.41, N 3.89. 
Suitable crystals of 19i for the X-ray crystal-structure determination were obtained by 
crystallization from EtOH/Et2O.  
4-Benzyl-1-methoxycarbonyl-8b-azaacenaphthylenium-5-olate (19j). GPB; 9a (120 
mg, 0.51 mmol), methyl propiolate (18e, 97 mg, 1.15 mmol). Yield of 19j: 43.5 mg (27%). 
Yellow-orange powder. M.p. 146.5–147.7°. IR (CHCl3): 3003m, 2954w, 1709s, 1633w, 
 28 
1579s, 1531m, 1515s, 1494w, 1453s, 1435s, 1412w, 1391m, 1336m, 1304s, 1241s, 1150s, 
1117s, 1080s, 1030w, 994w, 938w, 870w, 810w, 700m, 660w. 1H-NMR: 8.87 (d, J = 8.3, H–
C(6/8)); 8.64 (d, J = 7.6, H–C(8/6)); 7.97 (t, J = 8.2, H–C(7)); 7.89, 7.80 (2s, H–C(2), H–
C(3)); 7.36–7.15 (m, 5 arom. H); 4.13 (s, PhCH2); 4.00 (s, MeO). 13C-NMR: 175.2 (s, C(5)); 
164.5 (s, MeO2C); 139.3, 138.0, 137.3, 132.5 (4s, C(4), C(5a), C(8a), C(1) Ph); 129.7, 129.0, 
128.5, 126.8, 126.3, 123.5, 122.4, 119.0 (8d, C(2), C(3), C(6), C(7), C(8), 5 CH Ph); 120.5, 
112.6 (2s, C(1), C(2a)); 51.9 (q, MeO); 36.3 (t,PhCH2). CI-MS: 319 (18), 318 (100, [M+1]+). 
4-Benzyl-1-ethoxycarbonyl-2-methyl-8b-azaacenaphthylenium-5-olate (19k). GPC; 
9a (97 mg, 0.41 mmol), ethyl but-2-ynoate (18f, 100 mg, 0.43 mmol). Yield of 19k: 23 mg 
(32%). Orange powder. M.p. 134.5–135°. IR (CHCl3): 3007w, 2359w, 1698m, 1573s, 1530w, 
1496m, 1480m, 1435w, 1405w, 1384w, 1354w, 1295s, 1261s, 1154m, 1086s, 1046w, 1015w, 
810m, 688w. 1H-NMR: 8.79 (dd, J = 8.4, 0.9, H–C(6/8)); 8.59 (dd, J = 7.7, 1.0, H–C(8/6)); 
7.90 (t, J = 8.2, H–C(7)); 7.88 (s, H–C(3)); 7.40–7.20 (m, 5 arom. H); 4.48 (q, J = 7.2, 
MeCH2O); 4.16 (s, PhCH2); 2.79 (s, Me); 1.49 (t, J = 7.2, MeCH2O). 13C-NMR: 174.6 (s, 
C(5)); 164.5 (s, EtO2C); 139.3, 137.4, 136.4, 135.9, 131.9 (5s, C(2), C(4), C(5a), C(8a), C(1) 
Ph); 129.2, 128.6, 128.4, 126.3, 126.0, 122.3, 117.9 (7d, C(3), C(6), C(7), C(8), 5 CH Ph); 
120.5, 110.3 (2s, C(1), C(2a)); 60.2 (t, MeCH2O); 36.2 (t, PhCH2); 14.4 (q, MeCH2O); 11.7 
(q, Me). CI-MS: 347 (11), 346 (100, [M+1]+). 
1-Ethoxycarbonyl-4-methyl-2-trifluoromethyl-8b-azaacenaphthylenium-5-olate (19l). 
GPA; 9b (40 mg, 0.25 mmol), 18c (85 mg, 0.51 mmol). Yield of 19l: 33 mg (41%). Orange 
powder. IR (CHCl3): 3019m, 1730s, 1640m, 1542s, 1504m, 1474s, 1443m, 1409m, 1378m, 
1281s, 1239s, 1199s, 1151s, 1091s, 1025m, 899w, 815m, 665w. 1H-NMR (600 MHz): 8.99 
(dd, J = 8.6, 1.1, H–C(6/8)); 8.63 (dd, J = 7.5, 1.1, H–C(8/6)); 8.29 (d-like, J = 1.0, H–C(3)); 
7.96 (t, J = 7.5, H–C(7)); 4.50 (q, J = 7.1, 2 MeCH2O); 2.41 (d, J = 1.1, Me); 1.48 (t, J = 7.1, 
MeCH2O). 13C-NMR: 175.8 (s, C(5)); 162.3 (s, EtO2C); 147.4 (s, C(2)); 138.6, 136.5, 131.6 
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(3s, C(4), C(5a), C(8a)); 127.5, 126.7, 125.1, 120.0 (4d, C(3), C(6), C(7), C(8)); 122.9, 118.4 
(2s, C(1), C(2a)); 61.3 (t, MeCH2O); 17.2 (q, Me); 14.1 (q, MeCH2O). 19F-NMR (600 MHz, 
CDCl3, Cl3CF as reference): –55 (s, CF3). CI-MS: 325 (15), 324 (100, [M+1]+), 323 (38). 
Suitable crystals of 19l for the X-ray crystal-structure determination were obtained by 
crystallization from AcOEt.  
1-Methoxycarbonyl-4-methyl-8b-azaacenaphthylenium-5-olate (19m). GPB; 9b (157 
mg, 1.0 mmol), 18e (173 mg, 2.06 mmol). Yield of 19m: 71 mg (29%). Yellow powder. M.p. 
137.5–138.9°. IR (CHCl3): 3022m, 3007s, 2955m, 2927m, 1705s, 1635m, 1582s, 1530s, 
1516s, 1488m, 1455s, 1435s, 1419m, 1390s, 1379m, 1343m, 1331m, 1305s, 1244s, 1195m, 
1180m, 1150s, 1118s, 1085s, 1050m, 1019m, 972m, 944w, 935w, 904m, 871w, 815m, 609m. 
1H-NMR: 8.83 (d, J = 8.4, H–C(6/8)); 8.59 (d, J = 7.6, H–C(8/6)); 8.02 (s, H–C(3)); 7.00 (t, J 
= 7.4, H–C(7)); 4.01 (s, MeO); 2.39 (s, Me). 13C-NMR: 175.8 (s, C(5)); 164.4 (s, MeO2C); 
136.9, 134.6, 131.8 (3s, C(4), C(5a), C(8a)); 128.4, 125.9, 123.1, 121.6, 118.6 (5d, C(2), 
C(3), C(6), C(7), C(8)); 120.2, 112.1 (2s, C(1), C(2a)); 51.7 (q, MeO); 17.0 (q, Me). CI-MS: 
242 (100, [M+1]+). Anal. calc. for C14H11NO3 (241.25): C 69.70, H 4.60, N 5.81; found: C 
69.55, H 4.64, N 5.62. 
1-Ethoxycarbonyl-2,4-dimethyl-8b-azaacenaphthylenium-5-olate (19n). GPC; 9b (80 
mg, 0.50 mmol), 18f (131 mg, 1.2 mmol). Yield of 19n: 38 mg (28%). Orange powder. M.p. 
150.6–151.8°. IR (CHCl3): 3003m, 1703s, 1572s, 1530m, 1479m, 1434m, 1383m, 1292s, 
1272s, 1239s, 1169m, 1153m, 1090s, 814w, 663w. 1H-NMR: 8.70 (dd, J = 8.4, 1.0, H–
C(6/8)); 8.48 (dd, J = 7.7, 1.0, H–C(8/6)); 7.99 (d-like, J = 0.9, H–C(3)); 7.80 (t, J = 8.0, H–
C(7)); 4.41 (q, J = 7.1, MeCH2O); 2.78 (s, Me–C(2)); 2.34 (d, J = 0.8, Me–C(4)); 1.43 (t, J = 
7.1, MeCH2O). 13C-NMR: 175.5 (s, C(5)); 164.6 (s, EtO2C); 137.3, 135.3, 133.3, 131.4 (4s, 
C(2), C(4), C(5a), C(8a)); 126.1, 125.7, 122.1, 117.7 (4d, C(3), C(6), C(7), C(8)); 120.3, 
110.1 (2s, C(1), C(2a)); 60.2 (t, MeCH2O); 17.1 (q, Me–C(4)); 14.5 (q, MeCH2O); 11.6 (q, 
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Me–C(2)). CI-MS: 271 (26), 270 (100, [M+1]+). Anal. calc. for C16H15NO3 (269.30): C 71.36, 
H 5.61, N 5.20; found: C 71.19, H 5.32, N 5.27. 
1-Acetyl-4-methyl-8b-azaacenaphthylenium-5-olate (19o). GPC; 9b (80 mg, 0.50 
mmol), but-1-yn-3-one (102 mg, 1.5 mmol). Yield of 19o: 37 mg (27%). Orange oil. IR 
(CHCl3): 3006m, 2954m, 1711w, 1602s, 1579s, 1536m, 1511w, 1386m, 1304m, 1150m, 
1153m, 965w. 1H-NMR: 9.05 (dd, J = 8.3, 0.6, H–C(6/8)); 8.61 (dd, J = 7.7, 1.0, H–C(8/6)); 
8.02 (br. s, H–C(3)); 7.95 (t, J = 8.0, H–C(7)); 7.81 (s, H–C(2)); 2.69 (s, MeCO); 2.40 (d, J = 
0.5, Me). 13C-NMR: 193.5 (s, MeCO); 175.7 (s, C(5)); 136.3, 134.6, 131.5 (3s, C(4), C(5a), 
C(8a)); 128.3, 126.9, 124.2, 121.0, 118.9 (5d, C(2), C(3), C(6), C(7), C(8)); 120.3, 119.9 (2s, 
C(1), C(2a)); 16.9 (q, Me). CI-MS: 296 (9), 227 (15), 226 (100, [M+1]+). 
1-Ethoxycarbonyl-4-(prop-1-enyl)-2-trifluoromethyl-8b-azaacenaphthylenium-5-olate 
(19p). GPA; 9c (102 mg, 0.55 mmol), 18c (224 mg, 1.35 mmol). Yield of 19p: 63 mg (33%). 
Orange oil. IR (CHCl3): 3011m, 2956m, 1734s, 1640m, 1591s, 1504m, 1476m, 1443m, 
1393m, 1238s, 1199s, 1152s, 1081m, 1025m, 899w, 815m, 667w. 1H-NMR: 8.91 (d, J = 8.6, 
H–C(6/8); 8.56 (dd, J = 7.6, 0.9, H–C(8/6)); 8.27 (s, H–C(3)); 7.88 (t, J = 7.7, H–C(7)); 6.90–
6.65 (m, CH=CH); 4.43 (q, MeCH2O); 1.93 (d, J = 5.5, Me); 1.41 (t, J = 7.1, MeCH2O). CI-
MS: 352 (9), 351 (23), 350 (100, [M+1]+), 276 (7). 
1-Ethoxycarbonyl-4-isopropyl-2-trifluoromethyl-8b-azaacenaphthylenium-5-olate 
(19q). GPA; 9d (100 mg, 0.53 mmol), 18c (171 mg, 1.03 mmol). Yield of 19q: 67 mg (36%). 
IR (CHCl3): 3011m, 1733s, 1641m, 1547s, 1504m, 1473s, 1453m, 1410m, 1378m, 1282s, 
1237s, 1199s, 1161s, 1086s, 1023s, 812m, 695m. 1H-NMR: 8.92 (dd, J = 8.6, 0.9, H–C(6/8)); 
8.56 (dd, J = 7.5, 1.0, H–C(8/6)); 8.16 (s, H–C(3)); 7.89 (t, J = 7.6, H–C(7)); 4.43 (q, J = 7.1, 
MeCH2O); 3.30 (sept., J = 6.8, Me2CH); 1.22 (t, J = 7.1, MeCH2O); 1.10 (d, J = 6.8, Me2CH). 
CI-MS: 353 (24), 352 (100, [M+1]+). 
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5. Isolation of Side Products. - Diethyl 5-Benzyl-6-oxo-1-(2-pyridyl)cyclohexa-2,4-
dien-1,2-dicarboxylate (20a). A suspension of 9a (300 mg, 1.27 mmol) and 18a (607 mg, 
3.57 mmol) in toluene (5 ml) was heated to reflux for 17 min and then stirred at r.t. for 18 h. 
Evaporation of the solvent and CC (hexane/AcOEt 3:1) of the residue gave 19a (234 mg, 
45%) and 138 mg of a brown oil. CC of the latter (CH2Cl2/hexane 3:1) yielded 20a (42 mg, 
8%). Dark yellow oil. UV (EtOH): 326 (3.21). IR (CHCl3): 2984m, 2937w, 1753s, 1714s, 
1668s, 1585m, 1496w, 1465m, 1432m, 1371m, 1274s, 1137m, 1099m, 1030m, 999w, 864w, 
700w. 1H-NMR: 8.34 (ddd, J = 4.8, 1.7, 0.6, H–C(6) Pyr); 7.88 (d, J = 8.2, H–C(3) Pyr); 7.63 
(td, J = 7.8, 1.9, H–C(4) Pyr); 7.42 (d, J = 6.6, H–C(5) Pyr); 7.23–7.14 (m, 4 arom. H); 7.05–
7.02 (m, 1 arom. H, H–C(3)); 6.74 (dt, J = 6.6, 1.4, H–C(4)); 4.24–4.13 (m, 2 MeCH2O); 3.64 
(s, PhCH2); 1.19, 1.18 (2t, J = 7.1, 2 MeCH2O). 13C-NMR: 194.4 (s, C(6)); 167.4, 164.3 (2s, 2 
EtO2C); 155.4 (s, C(2) Pyr); 148.0 (d, C(6) Pyr); 139.6 (s, C(1) Ph); 138.1, 137.7 (2s, C(2), 
C(5)); 136.6 (d, C(4) Pyr); 136.0 (d, CH=C); 129.0, 128.3 (2d, 4 CH Ph); 129.3, 126.3, 125.6, 
123.0 (4d, 1 CH Ph, C(3) Pyr, C(5) Pyr, CH=C); 69.0 (s, C(1)); 62.0, 61.0 (2t, 2 MeCH2O); 
35.2 (t, PhCH2); 13.9, 13.8 (2q, 2 MeCH2O). CI-MS: 407 (23), 406 (100, [M+1]+). 
Dimethyl 5-Benzyl-6-oxo-1-(2-pyridyl)cyclohexa-2,4-dien-1,2-dicarboxylate (20b). A 
suspension of 9a (300 mg, 1.27 mmol) and 18b (650 mg, 4.57 mmol) in toluene (5 ml) was 
heated to reflux for 2 h and then stirred at r.t. for 10 h. Evaporation of the solvent and CC 
(hexane/AcOEt/CH2Cl2, 3×) of the residue gave 19b (160 mg, 33%) and 110 mg of a brown 
oil. CC of the latter (CH2Cl2/hexane 3:1) yielded 20b (29 mg, 6%). Yellow oil. IR (CHCl3): 
2983m, 1754s, 1711s, 1667s, 1582m, 1489w, 1432m, 1368m, 1275s, 1137m, 1099m, 1031m, 
995w, 864w, 698w. 1H-NMR: 8.34 (d, J = 4.1, H–C(6) Pyr); 7.83 (d, J = 8.0, H–C(3) Pyr); 
7.63 (td, J = 7.8, 1.7, H–C(4) Pyr); 7.40 (d, J = 6.6, H–C(5) Pyr); 7.29–7.15 (m, 4 arom. H); 
7.05–7.02 (m, 1 arom. H, H–C(3)); 6.70 (dt, J = 6.4, 1.4, H–C(4)); 3.73 (s, 2 MeO); 3.64 (s, 
PhCH2). 13C-NMR: 194.5 (s, C(6)); 168.0, 165.0 (2s, 2 MeO2C); 155.2 (s, C(2) Pyr); 148.2 
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(d, C(6) Pyr); 140.0 (s, C(1) Ph); 137.6 (s, C(2), C(5)); 136.5 (d, C(4) Pyr); 136.3 (d, CH=C); 
129.1, 128.5 (2d, 4 CH Ph); 129.7, 126.5, 125.7, 123.2 (4d, 1 CH Ph, C(3) Pyr, C(5) Pyr, 
CH=C); 69.0 (s, C(2)); 53.1, 52.2 (2q, 2 MeO); 35.3 (t, PhCH2). CI-MS: 379 (20), 378 (89, 
[M+1]+). 
Methyl 5-Benzyl-6-oxo-1-(2-pyridyl)cyclohexa-2,4-dien-1-carboxylate (20c). A 
mixture of 9a (242 mg, 1.03 mmol) and 18e (174 mg, 2.07 mmol) in toluene (10 ml) was 
heated to reflux for 30 min. Evaporation of the solvent and CC (hexane/AcOEt/CH2Cl2) of 
the residue gave 19j (74 mg, 23%), 20c (9 mg, 3%) as a yellow oil, and methyl 3-benzyl-6-(2-
pyridyl)salicylate (21, 3 mg, 1%). Data of 20c: IR (CHCl3): 3005w, 2956w, 1740s, 1664m, 
1645m, 1588m, 1495w, 1467m, 1453m, 1431s, 1396w, 1370m, 1220br, 1175m, 1076w, 
1030w, 1017w, 993w, 700w. 1H-NMR: 8.53 (d, J = 3.7, H–C(6) Pyr); 7.64 (td, J = 7.7, 1.9, 
H–C(4) Pyr); 7.32–7.16 (m, 7 arom. H); 6.71 (dd, J = 9.5, 0.9, H–C(2) or H–C(4)); 6.65 (dd, J 
= 6.6, 1.1, H–C(4) or H–C(2)); 6.39 (dd, J = 9.5, 6.2, H–C(3)); 3.74 (s, MeO); 3.69, 3.61 (2d, 
J = 17.2, PhCH2). 13C-NMR: 195.1 (s, C(6)); 169.0 (s, MeO2C); 157.1 (s, C(2) Pyr); 149.1 (d, 
C(6) Pyr); 138.5 (s, C(1) Ph); 138.0, 137.4, 136.7 (3d, C(4) Pyr, C(2), C(4)); 136.5 (s, C(5)); 
129.3, 128.4, 126.3, 123.8, 122.9, 122.5 (6d, C(3), C(3) Pyr, C(5) Pyr, 5 CH Ph); 69.1 (s, 
C(1)); 53.4 (q, MeO); 35.1 (t, PhCH2). CI-MS: 321 (15), 320 (100, [M+1]+), 262 (21), 261 
(25). 
Data of 21: IR (CHCl3): 3001w, 2963w, 1726m, 1673m, 1599s, 1495m, 1435s, 1374m, 
1272m, 1240m, 1216s, 1091w, 993w, 960w, 827w, 699w. 1H-NMR: 10.71 (br. s, OH); 8.60 
(dd, J = 4.2, 0.7, H–C(6) Pyr); 7.74 (td, J = 7.8, 1.8, H–C(4) Pyr); 7.40–7.10 (m, 8 arom. H); 
6.85 (d, J = 7.7, 1 arom. H); 4.06 (s, PhCH2); 3.45 (s, MeO). 13C-NMR: 171.2 (s, MeO2C); 
160.0, 158.9 (2s, C(2) Pyr, C–OH); 148.4 (d, C(6) Pyr); 141.2, 140.0, 129.9, 111.8 (4s, 4 
arom. C)); 136.0, 134.2, 128.9, 128.3, 126.0, 122.7, 121.6, 121.2 (8d, C(4) Pyr, C(3) Pyr, 
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C(5) Pyr, 7 arom. CH);  51.8 (q, MeO); 35.5 (t, PhCH2). CI-MS: 641 (11), 640 (37), 639 (82, 
[2M+1]+), 322 (12), 321 (23), 320 (100, [M+1]+). 
Dimethyl 5-Methyl-6-oxo-1-(2-pyridyl)cyclohexa-2,4-dien-1,2-dicarboxylate (20d). A 
soln. of 9b (300 mg, 1.9 mmol) and 18b (675 mg, 4.75 mmol) in THF (10 ml) was stirred at 
r.t. for 1 h. Evaporation of the solvent, CC and prep. DC of the residue gave 19d (213 mg, 
38%), 20d (21 mg, 5%) as a yellow oil, and dimethyl 3-hydroxy-4-methylphthalate (22, 22 
mg, 4%). Data of 20d: IR (CHCl3): 3391w, 3030m, 2953m, 2926w, 2848w, 2456w, 2359w, 
1758s, 1718s, 1667s, 1584m, 1572m, 1499w, 1464m, 1437s, 1380m, 1370m, 1350m, 1283s, 
1248s, 1138s, 1104m, 1075w, 1057w, 1037w, 1016w, 997w, 899w, 869w, 694w, 657w, 640w, 
614w. 1H-NMR: 8.29 (ddd, J = 4.8, 1.8, 1.1, H–C(6) Pyr); 7.90 (d, J = 8.2, H–C(3) Pyr); 7.63 
(td, J = 7.7, 1.7, H–C(4) Pyr); 7.35 (d, J = 6.5, H–C(3)); 7.12 (dt, J = 6.4, 1.0, H–C(5) Pyr); 
6.88 (dd, J = 6.5, 1.5, H–C(4)); 3.67 (s, 2 MeO); 1.86 (d, J = 1.4, Me). 13C-NMR: 195.4 (s, 
C(6)); 169.1, 165.3 (2s, 2 MeO2C); 155.9 (s, C(2) Pyr); 149.0 (d, C(6) Pyr); 137.5, 136.8 (2s, 
C(2), C(5)); 135.9, 134.2, 130.1, 123.0, 120.6 (5d, C(4) Pyr, C(3) Pyr, C(5) Pyr), C(3), C(4)); 
63.4 (s, C(1)); 51.6, 50.7 (2q, MeO); 16.8 (q, Me). CI-MS: 303 (17), 302 (100, [M+1]+), 206 
(23), 188 (10). 
Data of 22: IR (CHCl3): 3446 m (br.), 2955m, 2361w, 1733s, 1677s, 1584m, 1436s, 
1417m, 1282s, 1201s, 1156s, 1076m, 1031m, 1004m, 916w, 875m, 835m, 802m, 756m, 734m. 
1H-NMR: 10.69 (s, OH); 7.26 (d, J = 7.4, 1 arom. H); 6.82 (d, J = 7.5, 1 arom. H); 3.84, 3.80 
(2s, 2 MeO); 2.21 (s, Me). 13C-NMR: 167.0 (s, MeO2C); 159.1 (s, C–OH); 134.8, 122.1 (2d, 2 
arom. CH); 130.1, 128.9, 118.8 (3s, 3 arom. C); 50.6, 50.0 (2q, 2 MeO); 11.9 (q, Me). CI-MS: 
226 (10), 225 (100, [M+1]+), 195 (10), 193 (19). 
6. Attempted [2+3] Cycloadditions of 9 with Alkenes. A mixture of 9b (50 mg, 0.31 
mmol), fumaronitril (100 mg, 1.28 mmol), and a small amount of Pd/C in toluene (10 ml) was 
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heated to reflux for 4 d9). Then, the mixture was filtered through Celite and the solvent 
evaporated. The crude product and starting materials were separated by CC leading to 1,2-
Dicyano-4-methyl-8b-azaacenaphthylenium-5-olate (19r, 11 mg, 14%). 1H-NMR: 8.56 (dd, J 
= 7.5, 1.0, H–C(6/8)); 8.38 (dd, J = 8.7, 0.9, H–C(8/6)); 8.04 (s, H–C(3)); 7.96 (t, J = 7.5, H–
C(7)); 2.36 (s, Me). EI-MS: 235 (7), 234 (16), 233 (100, M+), 232 (27), 205 (10), 204 (55), 
203 (7), 169 (47), 150 (11), 147 (12), 119 11), 100 (6), 69 (29). 
The analogous reaction of 9b, dimethyl fumarate, and Pd/C in toluene gave 9d (7.5 
mg, 8%). All attempts with other dipolarophiles (e.g. dimethyl maleate, N-phenylmaleimide, 
tetracyanoethene, thiobenzophenone, thiofluorenone, etc.) were in vain. 
7. X-Ray Crystal-Structure Determination of 9a, 19i and 19l (Table 4 and Figs. 1 and 
2)10). All measurements were performed on a Rigaku AFC5R diffractometer using graphite-
monochromated MoKα radiation (λ 0.71069 Å) and a 12 kW rotating anode generator. The 
data collection and refinement parameters are given in the Table, and views of the molecules 
are shown in Figures 1 and 2. The intensities were corrected for Lorentz and polarization 
effects, but not for absorption. Equivalent reflections were merged. Each structure was solved 
by direct methods using SHELXS-86 [25], which revealed the positions of all non-H-atoms. 
The non-H-atoms were refined anisotropically. All of the H-atoms were located in difference 
electron density maps and their positions were allowed to refine together with individual 
isotropic displacement parameters. The refinement of each structure was carried out on F 
using full-matrix least-squares procedures [26], which minimized the function Σw(|Fo| – |Fc|)2. 
A correction for secondary extinction was applied in each case. Neutral atom scattering 
                                                 
9)  In the absence of Pd/C, only traces of 19r could be detected. 
10) CCDC-863882 – 863884 contain the supplementary crystallographic data for this paper. 
These data can be obtained free of charge from the Cambridge Crystallographic Data 
Centre via http://www.ccdc.cam.ac.uk/data_request/cif. 
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factors for non-H-atoms were taken from [27a], and the scattering factors for H-atoms were 
taken from [28]. Anomalous dispersion effects were included in Fc [29]; the values for f ' and 
f " were those of [27b]. The values of the mass attenuation coefficients are those of [27c]. All 
calculations were performed using the TEXSAN crystallographic software package [30]. 
 
Table. Crystallographic Data for Compounds 9a, 19i and 19l  
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Legends 
 
Table 1. Formation of 17 by Alkylation of Ketone 11 and Cyclization to give 2-
Alkylquinolizinium-1-olates 9 
 
Table 2. Formation of [2.3.3]Cyclazin-5-ones 19 via [2+3] Cycloaddition of  9 with 
Acetylene Dicarboxylates 18a,b 
 
Table 3. Formation of [2.3.3]Cyclazin-5-ones 19 via [2+3] Cycloaddition of  9 with 
Unsymmetrical Acetylene Carboxylates 18c – 18f 
 
Table 4.  Crystallographic Data for Compounds 9a, 19i, and 19l 
 
 
Fig. 1. ORTEP Plot [17] of the molecular structure of 9a (50% probability ellipsoids; 
arbitrary numbering of the atoms) 
 
Fig. 2. ORTEP Plots [17] of the molecular structures of a) 19i and b) 19l (50% 
probability ellipsoids; arbitrary numbering of the atoms) 
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Table 1. Formation of 17 via Alkylation of Ketone 11 and Cyclization to give 2-
Alkylquinolizinium-1-olates 9 
___________________________________________________________________________ 
 
R  17  Yield (%) 9 Yield (%) 
___________________________________________________________________________ 
 
PhCH2 a 63 a 87  
 
Me b 55 b 86 
 
H2C=CH–CH2 c 64 c a) 69 
 
Me2CH d 18 d 70 
 
HC≡C–CH2 e 64 e b) 21 
 
H 11  f  [11b] 10 
___________________________________________________________________________ 
a) 1-Propenyl derivative 
b) 2-[(1,3-Dioxolan-2-yl)methyl]-4-methylquinolizinium-1-olat 
 
Table 2. Formation of [2.3.3]Cyclazin-5-ones 19 via [2+3] Cycloaddition of  9 with 
Acetylene Dicarboxylates 18a, b 
___________________________________________________________________________ 
 
9 R R1   Procedure 19  Yield (%)  
___________________________________________________________________________ 
 
a PhCH2 EtO2C  Aa) a 36  (45)b) orange oil 
 
 MeO2C A b 40 orange powder,  
     m.p. 169–170° 
 
b Me EtO2C A c 29 orange oil 
 
 MeO2C A d 39 orange powder,  
     m.p. 148–149° 
 
c Me–CH=CH MeO2C A  e 33 orange oil 
 
d Me2CH MeO2C A  f 41 orange oil 
 
f H MeO2C A  g 19 orange oil 
___________________________________________________________________________ 
a) Reaction in THF at room temperature 
b) Reaction in toluene, 17 min. reflux, 18 h r.t.
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Table 3. Formation of [2.3.3]Cyclazin-5-ones 19 via [2+3] Cycloaddition of  9 with 
Unsymmetrical Acetylene Carboxylates 18c – 18f 
___________________________________________________________________________ 
 
9 R R1   R2 Procedure 19  Yield (%)  
___________________________________________________________________________ 
 
a PhCH2 EtO2C CF3 Aa) h 43 
 
  EtO2C H Bb) i 24 
 
  MeO2C H B j 27 
 
  EtO2C Me Cc)  k 32 
 
b Me EtO2C CF3 A  l 41 
  
  MeO2C H B  m 29 
 
  EtO2C Me C  n 28 
 
  MeCOd) H C  o 27 
 
c Me–CH=CH EtO2C CF3 A  p 33  
 
d Me2CH EtO2C CF3 A  q 36  
___________________________________________________________________________ 
a) Reaction in THF at room temperature 
b) Reaction in boiling toluene 
c) Reaction in toluene at 140° in a sealed tube 
d) Reaction with butin-3-one  
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Table 4.  Crystallographic Data for Compounds 9a, 19i, and 19l 
__________________________________________________________________________________ 
 
  9a  19i 
__________________________________________________________________________________ 
 
Crystallized from THF/hexane EtOH/Et2O 
Empirical formula C16H13NO C21H17NO3 
Formula weight 235.28 331.37  
Crystal color, habit yellow, prism orange, prism 
Crystal dimensions [mm] 0.22 × 0.38 × 0.43 0.25 × 0.30 × 0.52  
Temperature [K] 173(1) 173(1)  
Crystal system orthorhombic monoclinic  
Space group Pbca C2/m 
Z 8 4 
Reflections for cell determination 25 25  
2θ range for cell determination [°] 36–40 38–40 
Unit cell parameters a [Å] 24.982(2) 20.015(5) 
 b [Å] 13.317(1) 6.764(7)  
 c [Å] 7.171(1) 13.684(3) 
 β [°] 90 114.60(1) 
 V [Å3] 2385.6(4) 1684(2) 
Dx [g cm–3] 1.310 1.307  
µ(MoKα) [mm–1] 0.0818  0.0880   
Scan type ω  ω–2θ 
2θ(max) [°] 60 60  
Total reflections measured 4683 2715  
Symmetry independent reflections 3480 2646  
Reflections used in refinement 
[I>2σ(I)]a) 2062 1845  
Parameters refined 216 187  
Final R(F)  [I>2σ (I) reflections]a) 0.0443 0.0445   
 wR(F)  (all data) 0.0375 0.0421   
Weighting parameter [a]b) 0.005 0.005  
Goodness of fit 1.487 2.539  
Secondary extinction coefficient 2.3(3) × 10–7 2.01 × 10–7 
Final ∆max/σ 0.0004 0.0002  
∆ρ(max; min) [e Å–3] 0.26; –0.21 0.29; –0.21  
______________________________________________________________________ 
a) [I>3σ (I) reflections] for 19i; b) w–1 = σ 2(Fo) + (pFo)2  
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Table 4.  Crystallographic Data for Compounds 9a, 19i, and 19l (continued) 
__________________________________________________________________________________ 
 
  19l  
__________________________________________________________________________________ 
 
Crystallized from AcOEt  
Empirical formula C16H12F3NO3  
Formula weight 323.27   
Crystal color, habit orange, prism  
Crystal dimensions [mm] 0.30 × 0.35 × 0.48   
Temperature [K] 173(1)   
Crystal system monoclinic   
Space group P21/n  
Z 4  
Reflections for cell determination 25   
2θ range for cell determination [°] 39–40  
Unit cell parameters a [Å] 6.760(6)  
 b [Å] 12.410(4)   
 c [Å] 16.610(4)  
 β [°] 97.64(4)  
 V [Å3] 1381(1)  
Dx [g cm–3] 1.555   
µ(MoKα) [mm–1] 0.134     
Scan type ω/2θ  
2θ(max) [°] 55   
Total reflections measured 3594   
Symmetry independent reflections 3171   
Reflections used in refinement 
[I>2σ(I)]a) 2471  
Parameters refined 257   
Final R(F)  [I>2σ (I) reflections]a) 0.0560    
 wR(F)  (all data) 0.0625    
Weighting parameters [p]b) 0.005   
Goodness of fit 3.263   
Secondary extinction coefficient 5.80 × 10–7  
Final ∆max/σ 0.0006   
∆ρ(max; min) [e Å–3] 0.31; –0.30   
______________________________________________________________________ 
a) [I>3σ (I) reflections] for 9i; b) w–1 = σ 2(Fo) + (pFo)2  
 46 
 
 
 47 
Scheme 1 
 
 
 
Scheme 2 
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Scheme 3 
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Scheme 5 
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Scheme 7 
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Scheme 9 
 
 
 
Figure 1 
 
 
N
9b
O
Me
+
Toluene, ∆
Pd/C
N
O
Me
R R
19d (R = EtO2C, 8%)
    r  (R = CN, 14%)
R
R
23a R = EtO2C
    b R = CN
 52 
Figure 2 
a) b) 
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